05Jun
What We Learned From FDA's Public Hearing On Cannabis
The much-anticipated public hearing last week at the U.S. Food and Drug Administration on cannabis and cannabis-derived compounds drew a wide audience of participants, with strong views on how the FDA should (or should not) regulate the controversial...
By:
Sheppard Mullin Richter & Hampton LLP
Related
A forum selection clause is often included in an agreement in order to specify where any later dispu...
Read More >
It’s hard to keep up with all the recent changes to labor and employment law. While the law always ...
Read More >
Independent Contractor Agreements Should be Reviewed - With Assembly Bill 5 taking effect Jan. 1, p...
Read More >
While the Federal Arbitration Act (“FAA”) does not provide federal subject matter jurisdiction, fe...
Read More >
Welcome to our latest edition of Retail Rap. From influencer marketing to launching a startup and en...
Read More >
(Not a political endorsement.) As you know, this blog is non-partisan, even if it kills us. But I c...
Read More >